Evidence map›Paper›PMID 40030009›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Direct observation of cholesterol monohydrate crystallization.

Dipayan Chakraborty, Wenchuan Ma, Xiqu Wang, Zheting Chu, Taimin Yang, Monika Warzecha, Peter G Vekilov, Jeffrey D Rimer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. 3D cryoimaging of cell-mediated cholesterol crystal clearance in human atherosclerotic lesions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dipayan ChakrabortyWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004.
Wenchuan MaWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004.
Xiqu WangDepartment of Chemistry, University of Houston, Houston, TX 77204-5003.ORCID 0000-0003-3869-4426
Zheting ChuDepartment of Materials and Environmental Chemistry, Stockholm University, Stockholm SE-106 91, Sweden.
Taimin YangDepartment of Materials and Environmental Chemistry, Stockholm University, Stockholm SE-106 91, Sweden.
Monika WarzechaEngineering and Physical Sciences Research Council Continuous Manufacturing and Advanced Crystallisation Future Manufacturing Research Hub, c/o Strathclyde Institute of Pharmacy and Biomedical Sciences, Technology and Innovation Centre, Glasgow G1 1RD, United Kingdom.
Peter G VekilovWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004.ORCID 0000-0002-3424-8720
Jeffrey D RimerWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004.ORCID 0000-0002-2296-3428

Funding

Hematin crystallization in Plasmodium parasitesR21AI126215 · NIAID · UNIVERSITY OF HOUSTON · PI VEKILOV, PETER G · 2016 to 2017
$383k
HHS | NIH (NIH) 1R21AI126215-01NIAID NIH HHS R21 AI126215NSF (NSF) DMR-1710354NSF (NSF) DMR-2128121Welch Foundation (The Welch Foundation) E-1794Welch Foundation (The Welch Foundation) E-2170Welch Foundation (The Welch Foundation) V-E-0001
6 · The paper itself

Abstract

Cholesterol crystallization is integral to the pathology of diseases such as atherosclerosis and gallstones, yet the relevant mechanisms of crystal growth have remained elusive. Here, we use a variety of in situ techniques to examine cholesterol monohydrate crystallization over multiple length scales. In this study, we first identified a biomimetic solvent to generate triclinic monohydrate crystals, while avoiding the formation of nonphysiological solvates and enabling crystallization at rates where the dynamics of surface growth could be captured in real time. Using a binary mixture of water and isopropanol, with the latter serving as a surrogate for lipids in physiological environments, we show that cholesterol monohydrate crystals grow classically by the nucleation and spreading of crystal layers. Time-resolved imaging confirms that layers are generated by dislocations and monomers incorporate into advancing steps after diffusion along the crystal surface and not directly from the solution. In situ atomic force microscopy (AFM) and microfluidics measurements concertedly reveal abundant macrosteps, which engender a self-inhibition mechanism that reduces the rate of crystal growth. This finding stands in contrast to numerous other systems, in which classical mechanisms lead to unhindered growth by spreading of single layers.

Indexed as

Cholesterol2-PropanolCrystallizationMicrofluidicsMicroscopy, Atomic ForceWater2-PropanolCholesterolWateratomic force microscopycholesterol monohydratecrystal growthmicrofluidics

Identifiers

PMID40030009
PMCPMC11912462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.